Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The risk is severe: if the courts find for the innovator, the generic manufacturer faces liability for the innovators lost profits, which for a blockbuster drug can reach into the billions of dollars
Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV
Not intended for children, and not a substitute for medical or dermatological treatment of skin conditions
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial
Mima, H
US$ 28.63
US$ 23.27
US$ 24.93
